Characteristics and Outcomes in Women and Men in the Connect ® CLL Registry

Previous studies prior to BCR-targeted agents suggest that women with chronic lymphocytic leukemia (CLL) have a more indolent clinical course, better responses to treatment, and improved survival than men.

Source: Clinical Lymphoma, Myeloma and Leukemia - August 26, 2016 Category: Hematology Authors: Spencer Bachow, Chadi Nabhan, Anthony Mato, Christopher Flowers, Neil Kay, David Grinblatt, Matthew Davids, Mark Weiss, Kristen Sullivan, E. Dawn Flick, Pavel Kiselev, Shriya Bhushan, Arlene Swern, Jeff Sharman, Nicole Lamanna Source Type: research